BETULINDERIVATE

Patent europeic · EP2791103 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2791103
Numer da la dumonda
EP12857774
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
14-12-2012
Publitgà
22-10-2014
Concedì
02-08-2017
Stritgà
31-12-2020
Motiv
Taxa annuala betg pajada
Classas IPC
C07C 69/753 (2006.01)
C07J 63/00 (2006.01)
A61K 31/56 (2006.01)
A61P 31/18 (2006.01)
Prioritad
US 201161576448 P 16.12.2011
Dumonda PCT
PCT/US2012/069637 14.12.2012
Publicaziun PCT
WO2013/090664 20.06.2013
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 21-07-2021

    Stritgà, taxa betg pajada

    Published in Swissreg on 21.07.2021

  2. 12-09-2017

    Represchentant inscrit

    Representative
    Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in Swissreg on 12.09.2017

  3. 02-08-2017

    Concedì

    Published in Swissreg on 02.08.2017

Partidas

Possessur

GlaxoSmithKline LLC

251 Little Falls Drive, Wilmington, Delaware 19808, US

Represchentant

Isler & Pedrazzini AG

Postfach 1772, 8027 Zürich

Inventur

HATCHER, Mark Andrew

Research Triangle Park, North Carolina 27709, US

JOHNS, Brian, Alvin

Research Triangle Park, North Carolina 27709, US

MARTIN, Michael, Tolar

Research Triangle Park, North Carolina 27709, US

TABET, Elie, Amine

Research Triangle Park, North Carolina 27709, US

TANG, Jun

Research Triangle Park, North Carolina 27709, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.